{
  "id": "_b3423",
  "type": "CriterionAssessment",
  "criterion": {
    "id": "SEPIO-CG:99038",
    "type": "Criterion",
    "label": "BA1",
    "description": "Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium",
    "defaultStrength": {
      "id": "SEPIO:0000325",
      "type": "EvidenceLineStrength",
      "label": "Benign Stand Alone"
    },
    "comments": "Several groups have lowered the BA1 threshold (e.g. PTEN-1%). Also the sequence variant interpretation group is working on a modified version of this guideline including the minimum # of alleles that need to be examined and the population stratification effects, if any."
  },
  "variant": {
    "id": "CAR:CA134997",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "_b181",
      "type": "ContextualAllele",
      "relatedCanonicalAllele": "CanAll076",
      "alleleName": "NM_004004.5(GJB2):c.79G>A"
    }
  },
  "outcome": {
    "id": "SEPIO:0000223",
    "type": "CriterionEvaluation",
    "label": "Met"
  },
  "evidenceLine": [
    {
      "id": "_b2160",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "_b3253",
          "type": "AlleleFrequency",
          "ascertainment": {
            "id": "SEPIO:0000332",
            "type": "Ascertainment",
            "label": "ExAc ascertainment method"
          },
          "population": {
            "id": "SEPIO-CG:98001",
            "type": "Population",
            "label": "Combined"
          },
          "allele": {
            "id": "CAR:CA134997",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "_b181",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll076",
              "alleleName": "NM_004004.5(GJB2):c.79G>A"
            }
          },
          "alleleCount": 5507,
          "alleleNumber": 121350,
          "alleleFrequency": 0.04538,
          "homozygousAlleleIndividualCount": 768
        }
      ]
    },
    {
      "id": "_b2161",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "_b3254",
          "type": "AlleleFrequency",
          "ascertainment": {
            "id": "SEPIO:0000332",
            "type": "Ascertainment",
            "label": "ExAc ascertainment method"
          },
          "population": {
            "id": "BROAD-population-type:eas",
            "type": "Population",
            "label": "East Asian"
          },
          "allele": {
            "id": "CAR:CA134997",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "_b181",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll076",
              "alleleName": "NM_004004.5(GJB2):c.79G>A"
            }
          },
          "alleleCount": 2518,
          "alleleNumber": 8632,
          "alleleFrequency": 0.2917,
          "homozygousAlleleIndividualCount": 405
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent001",
        "type": "Agent",
        "label": "Harry Stevenson"
      },
      "contributionDate": "8/29/16 8:00 PM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "description": "Globally, this variant has a MAF of 0.0454 (4.5%) which would put it under the 5% rule and thus BA1 would not be applicable. However, variant is enriched in East Asian population - 29% MAF - so way over the 5% cut-off. So now BA1 is applicable",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
